Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma

Tadashi Hanafusa, Yasuhiro Yumoto, Kazuhiro Nouso, Harushige Nakatsukasa, Toru Onishi, Tatsuya Fujikawa, Mayumi Taniyama, Shinichiro Nakamura, Masayuki Uemura, Yoshitaka Takuma, Eiichiro Yumoto, Toshihiro Higashi, Takao Tsuji

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Insulin-like growth factor binding protein-3 (IGFBP-3) is postulated to be a mediator of growth suppression signals. Reduced expression of the IGFBP-3 was observed in nine out of 12 human hepatocellular carcinomas (HCC) (75%). Promoter hypermethylation of the IGFBP-3 was detected in four out of 12 HCCs (33%) although mutations were not identified. The expression of IGFBP-3 was restored by the demethylating agent 5-aza-2′-deoxycytidine in HCC cell line with promoter hypermethylation (HepG2). As IGFBP-3 functions like a tumor suppressor gene, it may be used as a therapeutic target for HCC.

Original languageEnglish
Pages (from-to)149-158
Number of pages10
JournalCancer Letters
Volume176
Issue number2
DOIs
Publication statusPublished - Feb 25 2002

Fingerprint

Insulin-Like Growth Factor Binding Protein 3
Hepatocellular Carcinoma
decitabine
Tumor Suppressor Genes
Cell Line
Mutation
Growth

Keywords

  • cDNA microarray
  • Hepatocellular carcinoma
  • Hypermethylation
  • Insulin-like growth factor binding protein-3
  • Mannose 6-phosphate/insulin-like growth factor 2 receptor

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. / Hanafusa, Tadashi; Yumoto, Yasuhiro; Nouso, Kazuhiro; Nakatsukasa, Harushige; Onishi, Toru; Fujikawa, Tatsuya; Taniyama, Mayumi; Nakamura, Shinichiro; Uemura, Masayuki; Takuma, Yoshitaka; Yumoto, Eiichiro; Higashi, Toshihiro; Tsuji, Takao.

In: Cancer Letters, Vol. 176, No. 2, 25.02.2002, p. 149-158.

Research output: Contribution to journalArticle

Hanafusa, T, Yumoto, Y, Nouso, K, Nakatsukasa, H, Onishi, T, Fujikawa, T, Taniyama, M, Nakamura, S, Uemura, M, Takuma, Y, Yumoto, E, Higashi, T & Tsuji, T 2002, 'Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma', Cancer Letters, vol. 176, no. 2, pp. 149-158. https://doi.org/10.1016/S0304-3835(01)00736-4
Hanafusa, Tadashi ; Yumoto, Yasuhiro ; Nouso, Kazuhiro ; Nakatsukasa, Harushige ; Onishi, Toru ; Fujikawa, Tatsuya ; Taniyama, Mayumi ; Nakamura, Shinichiro ; Uemura, Masayuki ; Takuma, Yoshitaka ; Yumoto, Eiichiro ; Higashi, Toshihiro ; Tsuji, Takao. / Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. In: Cancer Letters. 2002 ; Vol. 176, No. 2. pp. 149-158.
@article{b35d21a92b6848d3ad3f12ed289453ff,
title = "Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma",
abstract = "Insulin-like growth factor binding protein-3 (IGFBP-3) is postulated to be a mediator of growth suppression signals. Reduced expression of the IGFBP-3 was observed in nine out of 12 human hepatocellular carcinomas (HCC) (75{\%}). Promoter hypermethylation of the IGFBP-3 was detected in four out of 12 HCCs (33{\%}) although mutations were not identified. The expression of IGFBP-3 was restored by the demethylating agent 5-aza-2′-deoxycytidine in HCC cell line with promoter hypermethylation (HepG2). As IGFBP-3 functions like a tumor suppressor gene, it may be used as a therapeutic target for HCC.",
keywords = "cDNA microarray, Hepatocellular carcinoma, Hypermethylation, Insulin-like growth factor binding protein-3, Mannose 6-phosphate/insulin-like growth factor 2 receptor",
author = "Tadashi Hanafusa and Yasuhiro Yumoto and Kazuhiro Nouso and Harushige Nakatsukasa and Toru Onishi and Tatsuya Fujikawa and Mayumi Taniyama and Shinichiro Nakamura and Masayuki Uemura and Yoshitaka Takuma and Eiichiro Yumoto and Toshihiro Higashi and Takao Tsuji",
year = "2002",
month = "2",
day = "25",
doi = "10.1016/S0304-3835(01)00736-4",
language = "English",
volume = "176",
pages = "149--158",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma

AU - Hanafusa, Tadashi

AU - Yumoto, Yasuhiro

AU - Nouso, Kazuhiro

AU - Nakatsukasa, Harushige

AU - Onishi, Toru

AU - Fujikawa, Tatsuya

AU - Taniyama, Mayumi

AU - Nakamura, Shinichiro

AU - Uemura, Masayuki

AU - Takuma, Yoshitaka

AU - Yumoto, Eiichiro

AU - Higashi, Toshihiro

AU - Tsuji, Takao

PY - 2002/2/25

Y1 - 2002/2/25

N2 - Insulin-like growth factor binding protein-3 (IGFBP-3) is postulated to be a mediator of growth suppression signals. Reduced expression of the IGFBP-3 was observed in nine out of 12 human hepatocellular carcinomas (HCC) (75%). Promoter hypermethylation of the IGFBP-3 was detected in four out of 12 HCCs (33%) although mutations were not identified. The expression of IGFBP-3 was restored by the demethylating agent 5-aza-2′-deoxycytidine in HCC cell line with promoter hypermethylation (HepG2). As IGFBP-3 functions like a tumor suppressor gene, it may be used as a therapeutic target for HCC.

AB - Insulin-like growth factor binding protein-3 (IGFBP-3) is postulated to be a mediator of growth suppression signals. Reduced expression of the IGFBP-3 was observed in nine out of 12 human hepatocellular carcinomas (HCC) (75%). Promoter hypermethylation of the IGFBP-3 was detected in four out of 12 HCCs (33%) although mutations were not identified. The expression of IGFBP-3 was restored by the demethylating agent 5-aza-2′-deoxycytidine in HCC cell line with promoter hypermethylation (HepG2). As IGFBP-3 functions like a tumor suppressor gene, it may be used as a therapeutic target for HCC.

KW - cDNA microarray

KW - Hepatocellular carcinoma

KW - Hypermethylation

KW - Insulin-like growth factor binding protein-3

KW - Mannose 6-phosphate/insulin-like growth factor 2 receptor

UR - http://www.scopus.com/inward/record.url?scp=18244401685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244401685&partnerID=8YFLogxK

U2 - 10.1016/S0304-3835(01)00736-4

DO - 10.1016/S0304-3835(01)00736-4

M3 - Article

VL - 176

SP - 149

EP - 158

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -